Dark Forest Capital Management LP Rocket Pharmaceuticals, Inc. Transaction History

Dark Forest Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$15.79 - $22.6 $75,634 - $108,254	4,790 New	4,790 $82,000
Q2 2022 Aug 15, 2022	BUY	$7.96 - $16.64 $2,109 - $4,409	265 New	265 $4,000
Q1 2022 May 13, 2022	SELL	$13.16 - $23.68 $4,290 - $7,719	-326 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$21.52 - $36.02 $7,359 - $12,318	-342 Reduced 51.2%	326 $7,000
Q3 2021 Nov 12, 2021	BUY	$27.42 - $48.97 $18,316 - $32,711	668 New	668 $20,000

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.07B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.